Lumantas, Maria Leonora .
HRN: 16-93-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
CEFTRIAXONE 1G (VIAL)
11/24/2022
11/30/2022
IV
2g
Q 24H
Ductal Carcinoma, L Breast
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes